Safety of use of antiarrhythmic drugs
Mehta, D.; Saxena, A.
Indian Heart Journal 42(6): 445-450
1990
ISSN/ISBN: 0019-4832 PMID: 2098318 Document Number: 360750
Document emailed within 1 workday
Related Documents
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355Usuda, K.; Ikeda, T. 1991: Drug induced arrhythmias (digitalis, antiarrhythmic drugs and other drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2666-2671
Horgan, J.H.; Teo, K.K.; Harte, M. 1982: Modern drugs treatment--No. 11. Antiarrhythmic drugs Irish Medical Journal 75(11): 426-427; 429-432
Ignat'ev, M.V. 1975: Some new antiarrhythmic drugs Voenno-Meditsinskii Zhurnal 1: 73-74
Hoffman, B.F. 1997: Arrhythmias and antiarrhythmic drugs Mount Sinai Journal of Medicine new York 64(2): 136-141
Kock-Weser, J. 1975: Pharmacokinetics of antiarrhythmic drugs Cardiovascular Clinics 7(2): 191-202
Coumel, P.; Thomas, O. 1997: Antiarrhythmic drugs: how to use and to evaluate them Le Journal Medical Libanais. Lebanese Medical Journal 45(4): 221-223
Abdalla, A.; Mazur, N.A.; Shestakova, N.V.; Nazarenko, V.A. 1991: Assessment of the efficacy and safety of class IC antiarrhythmic drug combinations Terapevticheskii Arkhiv 63(1): 56-59
Harrison, D.C.; Irwin, W.G. 1981: New concepts for antiarrhythmic drugs in the 1980's Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 73-77
Reiffel, J.A. 2001: Issues in the use of generic antiarrhythmic drugs Current Opinion in Cardiology 16(1): 23-29
Goldberg, P.B.; Stoner, S.A.; Roberts, J. 1978: Influence of age on activity of antiarrhythmic drugs in rat heart Advances in Experimental Medicine and Biology 97: 309-313
Caillard, C.G.; Louis, J.C. 1980: Assessment of antiarrhythmic drugs in experimental pharmacology Methods and Findings in Experimental and Clinical Pharmacology 2(5): 223-252
Roden, D.M. 1985: Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents Postgraduate Medicine 78(4): 28-37
He, R.; Du, X.; Liu, S.W.; Sun, L.J.; Li, Y.; Zeng, H.; Li, Y.Y.; Sun, C.; Zhang, Y.; Ma, C.S.; Gao, W. 2016: Current status of antiarrhythmic drug use and safety assessment in Chinese patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 44(11): 935-939
Alboni, P.; Gianfranchi, L.; Pacchioni, F.; Pedaci, M. 2005: Antiarrhythmic drugs in patients with recurrent atrial fibrillation: where are we? Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(3): 169-174
Yamashita, T.; Sugimoto, T. 1991: Medical management of arrhythmias; newer antiarrhythmic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2680-2686
Josephson, M.A.; Singh, B.N. 1986: Hemodynamic effects of N-acetylprocainamide in man: comparison with other antiarrhythmic drugs Angiology 37(12 Part 2): 950-958
Goedel-Meinen, L.; Schmidt, G.; Jahns, G.; Klein, G.; Wirtzfeld, A.; Baedeker, W.; Blömer, H. 1986: Antiarrhythmic drugs in advanced organic heart disease British Journal of Clinical Practice. Suppl 44: 28-30
Adams, H.R. 1986: New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs Journal of the American Veterinary Medical Association 189(5): 525-532
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47